Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on: January 28,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on:January 28,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on: March 30,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on:March 30,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on: June 06,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on:June 06,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on: February 24,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on:February 24,2024

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n

Updated on: March 14,2024

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n

Updated on:March 14,2024

In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

by University of Massachusetts AmherstTreatment approaches for breast cancer dormancy. Plausible therapeutic pathway targets to (A) directly kill, (B) maintain, or (C) activate and then kill dorm

Updated on: March 30,2024

In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

by University of Massachusetts AmherstTreatment approaches for breast cancer dormancy. Plausible therapeutic pathway targets to (A) directly kill, (B) maintain, or (C) activate and then kill dorm

Updated on:March 30,2024

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on: July 05,2024

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on:July 05,2024

New drug combination offers hope to women with rare treatment-resistant ovarian cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainA combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ovarian ca

Updated on: November 09,2024

New drug combination offers hope to women with rare treatment-resistant ovarian cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainA combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ovarian ca

Updated on:November 09,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on: October 21,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on:October 21,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in

Updated on: January 11,2024

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in

Updated on:January 11,2024

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Updated on: March 05,2024

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Updated on:March 05,2024